Venture Investment & Partnering (VIP) Forums
of the WBBA’s objectives is to assist life science companies,
entrepreneurs and researchers in bridging the gap between discovery and
commercialization. To this end, WBBA has an exciting program called
Venture Investment & Partnering (VIP) Forums. VIP Forums present a
unique opportunity for local life science entrepreneurs, companies and
researchers to meet with quality investors and strategic partners. We
invite venture capital firms, corporate venture groups and multinational
strategics (VIPs) to Seattle for a two-part event.
WBBA hosts a Plenary Session during which the VIP discusses their
targets, interests, and investment/partnering strategies, and answers
questions from the audience. The Plenary Session is followed by a
networking reception. Second, pre-selected organizations present their
investment and partnering opportunities to the VIP in a one-on-one
Previous VIPs include LongTech Medical, Johnson & Johnson Development Corp.,Shire
Pharmaceuticals, C.R. Bard, MedImmune Ventures and Partnering, H.I.G.
BioVentures, Bristol-Myers Squibb, Bayer Healthcare, Merck Global Health
Innovation, Takeda Ventures, Johnson & Johnson’s COSAT, BioWa,
Inc., Essex Woodlands, NEA and OrbiMed.
There are no fees associated with this event; companies chosen for 1:1 meetings MUST be WBBA members.
VIP Forums are made possible by the partnership and generous support of:
If you have questions or are interested in visiting Seattle as a VIP or sponsoring VIP Forums, please contact email@example.com
Recent VIP Forums
April 15-16, 2014: Eli Lilly and Company
December 5-6, 2013: Novo Nordisk